+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Companies in China

  • PDF Icon

    Report

  • 78 Pages
  • June 2023
  • Region: China
  • AMID Co
  • ID: 3447719

China's demand for Cardiovascular Drugs will continue to grow at about 12% by 2032

This study focuses on China’s Cardiovascular Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumption in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumption of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. CARDIOVASCULAR DRUGS INDUSTRY ASSESSMENTS
  • Cardiovascular Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Major Producer Facility Locations and Output
  • Major Producer Facility Locations
  • Major Producer Facility Locations and Output
  • Market Share of Key Producers
  • Labor Costs
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
III. CARDIOVASCULAR DRUGS PRODUCER DIRECTORY
  • Western Cardiovascular Drug. Producers Profiles
  • Chinese Traditional Cardiovascular Drugs Producers Profiles
LIST OF TABLES
I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. CARDIOVASCULAR DRUGS INDUSTRY ASSESSMENTS
  • Major Producer Facility Locations
  • Major Producers Output
  • Cardiovascular Drugs Producers Output and Their Market Share
  • Major Foreign Investments
LIST OF CHARTS
I. INTRODUCTION
  • China’s Cardiovascular Drugs Total Output and Demand
II. CARDIOVASCULAR DRUGS INDUSTRY ASSESSMENTS
  • Total Cardiovascular Drugs Output and Demand

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Beijing Double-Crane Pharmaceutical Co.,Ltd
  • Tasly Pharmaceutical Co.,Ltd